NCT00418249Unknown2 期
Phase 2 Study of Topical AS101 for the Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women
适应症
相关药物
试验速览
- 阶段
- 2 期
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- hair density
研究概览
简要总结
The primary objective of this study is to assess the safety and efficacy of topical AS101 as treatment for Female Androgenetic Alopecia (FAGA) in menopause women.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 50 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Women in menopause, over 50 years of age.
- •Clinically diagnosed for AGA, according to Ludwig scale I-II.
排除标准
- •Women treated with chronic medications.
- •Use of Minoxidil within 3 months prior to entering study.
- •Women who have underwent hair transplantation.
- •Use of drugs with androgenic or anti-androgenic effects.
- •Any other type of hair loss.
结局指标
主要结局
hair density
次要结局
- Self-administered satisfaction questionnaire
- Hair diameter, anagen/telogen ratio and hair growth rate,Global photographic assessment according to Female-Ludwig scale,
研究者
研究点 (1)
Loading locations...
相似试验
撤回
2 期
Topical Application of AS101 for the Treatment of PsoriasisMild to Moderate PsoriasisNCT00788424BioMAS Ltd
Unknown
2 期
Safety and Efficacy Double Blind Vehicle Controlled Study of 15% AS101 Gel to Treat External Genital WartsExternal Genital WartsNCT01943630BioMAS Ltd60
已完成
1 期
Safety and Efficacy Study to Test Topical AS101 for External Genital WartsCondyloma AcuminataExternal Genital Organs WartNCT01555112BioMAS Ltd12
终止
2 期
ATX-101 in Advanced Dedifferentiated Liposarcoma and LeiomyosarcomaLeiomyosarcomaLiposarcomaNCT05116683Benjamin Izar4
撤回
2 期
Efficacy and Safety of SM101 in the Treatment of IgA NephropathyImmunoglobulin A NephropathyNCT02605525Baxalta now part of Shire